In light of these advantages and disadvantages, if the effects of Pg-LPS can be evaluated using a medaka model of NASH in this study, it will enable large-scale screening at a lower cost and in a smaller space than in mammals and establish a model for the complications of NASH and periodontal disease. Here, JUP is linked to metabolic dysfunction-associated steatohepatitis.